Injection drug network characteristics are important markers of HIV risk behavior and lack of viral suppression.

Cepeda, Javier A.; Solomon, Sunil S.; Srikrishnan, Aylur K.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes ., Post Acceptance: March 20, 2017

Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine–Naloxone: HIV Prevention Trials Network 058

Metzger, David S.; Donnell, Deborah; Celentano, David D.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 68(5):554-561, April 15, 2015.